Clinical Trials Directory

Trials / Completed

CompletedNCT03946813

The Efficacy of Platelets Rich Plasma for Ovarian Rejuvenation

The Efficacy of Platelets Rich Plasma (PRP) for Ovarian Rejuvenation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Al-Kindy College of Medicine · Academic / Other
Sex
Female
Age
20 Years – 49 Years
Healthy volunteers
Not accepted

Summary

In recent years, an increased approach has appeared in the use of autologous blood products to assist tissue and organ healing. Application of platelet rich plasma (PRP) has emerged as a potential solution for infertile women with poor ovarian reserve in reproductive specialty.

Detailed description

Quantitative and qualitative functional improvement of ovarian function has been reported in several studies after using autologous PRP in a reproductive field. Ovarian rejuvenation, stimulating the ovaries to produce new eggs after injecting PRP, can offer hope for renewed fertility to women with poor reserve volume, advanced maternal age, or either naturally occurring or premature menopause. But, these encouraging results should be supported by several new studies. This study aimed to estimate the efficacy of trans-vaginal ovarian injection with PRP in rejuvenates ovaries in woman with poor ovarian reserve, and to assess any association of some women variables (age, menstrual status, parity, BMI) as predicting factors in success of ovarian injection with PRP.

Conditions

Interventions

TypeNameDescription
OTHERAutologous PRP preparationFor each patient, autologous PRP preparation havs to be injected to both ovaries and ultrasound (US) guide

Timeline

Start date
2018-08-20
Primary completion
2019-05-31
Completion
2019-05-31
First posted
2019-05-13
Last updated
2023-05-06

Locations

1 site across 1 country: Iraq

Source: ClinicalTrials.gov record NCT03946813. Inclusion in this directory is not an endorsement.